PGHH - Procter & Gamble Hygiene & Health Care Ltd. Share Price

Personal Products

₹14214.00+566.00(+4.15%)

Market Closed as of Sep 29, 2025, 15:30 IST

Select time range

Valuation
Market Cap	46.14 kCr
Price/Earnings (Trailing)	61.72
Price/Sales (Trailing)	13.5
EV/EBITDA	43.22
Price/Free Cashflow	85.73
MarketCap/EBT	45.48
Enterprise Value	45.67 kCr

Fundamentals
Revenue (TTM)	3.42 kCr
Rev. Growth (Yr)	0.60%
Earnings (TTM)	747.59 Cr
Earnings Growth (Yr)	136.9%

Profitability
Operating Margin	30%
EBT Margin	30%
Return on Equity	101.44%
Return on Assets	42.6%
Free Cashflow Yield	1.17%

Price to Sales Ratio

Latest reported: 14

Revenue (Last 12 mths)

Latest reported: 3 kCr

Net Income (Last 12 mths)

Latest reported: 748 Cr

Growth & Returns
Price Change 1W	5%
Price Change 1M	8.6%
Price Change 6M	3.8%
Price Change 1Y	-13.4%
3Y Cumulative Return	0.80%
5Y Cumulative Return	7.4%
7Y Cumulative Return	5.8%
10Y Cumulative Return	8.6%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-34.28 Cr
Cash Flow from Operations (TTM)	593.21 Cr
Cash Flow from Financing (TTM)	-666.23 Cr
Cash & Equivalents	466.37 Cr
Free Cash Flow (TTM)	538.18 Cr
Free Cash Flow/Share (TTM)	165.79

Balance Sheet
Total Assets	1.75 kCr
Total Liabilities	1.02 kCr
Shareholder Equity	736.99 Cr
Current Assets	1.09 kCr
Current Liabilities	901.06 Cr
Net PPE	131.37 Cr
Inventory	221.4 Cr
Goodwill	0.00

Capital Structure & Leverage
Debt Ratio	0.00
Debt/Equity	0.00
Interest Coverage	69.21
Interest/Cashflow Ops	42.05

Dividend & Shareholder Returns
Dividend/Share (TTM)	270
Dividend Yield	1.9%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Pros

Size: Market Cap wise it is among the top 20% companies of india.

Smart Money: Smart money has been increasing their position in the stock.

Profitability: Very strong Profitability. One year profit margin are 22%.

Momentum: Stock price has a strong positive momentum. Stock is up 8.6% in last 30 days.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Balance Sheet: Strong Balance Sheet.

Cons

Growth: Declining Revenues! Trailing 12m revenue has fallen by -19.7% in past one year. In past three years, revenues have changed by -12.9%.

Past Returns: Underperforming stock! In past three years, the stock has provided 0.8% return compared to 11.2% by NIFTY 50.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Dividend Yield	1.9%
Dividend/Share (TTM)	270
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	230.31

Financial Health
Current Ratio	1.21
Debt/Equity	0.00

Technical Indicators
RSI (14d)	59.63
RSI (5d)	42.66
RSI (21d)	60.03
MACD Signal	Buy
Stochastic Oscillator Signal	Hold
Grufity Signal	Buy
RSI Signal	Hold
RSI5 Signal	Hold
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Latest News and Updates from Procter & Gamble Hygiene & Health Care

Updated May 5, 2025

The Bad News

NBC Chicago

Procter & Gamble's revenue of $19.78 billion fell short of the anticipated $20.11 billion.

NBC Chicago

The company cut its full-year core earnings and revenue forecasts due to a consumer slowdown and rising tariffs.

Business Insider

Insider selling has increased, including a significant sale by CEO Gary Coombe, which suggests negative sentiment about the stock.

The Good News

Business Insider

J.P. Morgan analyst Andrea Faria Teixeira maintained a Buy rating on Procter & Gamble with a price target of $169.00.

moneycontrol.com

Truist Financial also gave a Buy rating for Procter & Gamble, with a higher price target of $180.00.

NBC Chicago

Procter & Gamble reported quarterly earnings of $1.54 per share, surpassing expectations.

Updates from Procter & Gamble Hygiene & Health Care

Change in Directorate • 05 Sept 2025

Intimation regarding re-appointment of Mr. Chittranjan Dua as Independent Director of the Company

Change in Directorate • 05 Sept 2025

Dear Sir, Please find attached intimation regarding re-appointment of Mr. Krishnamurthy Iyer as Independent Director of the Company.

Change in Directorate • 30 Jul 2025

This is to inform that Mr. Chittranjan Dua has been reappointed as Independent Director of the Company for a period of five years effective August 25, 2025, subject to approval of the Shareholders ....

Change in Directorate • 30 Jul 2025

Dear Sir, Please be informed that Mr. Krishnamurthy Iyer, has been re-appointed as Independent Director of the Company effective December 1, 2025, for a period of five years, subject ....

General • 30 Jul 2025

Please find attached press release for the quarter ended June 30, 2025.

Resignation of Director • 23 Jul 2025

Dear Sir, Please find attached intimation regarding cessation of Mr. Gagan Sawhney as Non-Executive Director of the Company effective October 5, 2025. Request you to kindly take note ....

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 • 15 Jul 2025

Dear Sir Please find attached certificate under regulation 74(5) of SEBI (DP) Regulations, for the quarter ended June 30, 2025

This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.

Summary of Latest Earnings Report from Procter & Gamble Hygiene & Health Care

Summary of Procter & Gamble Hygiene & Health Care's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated:

Q&A Session

Last updated:

Share Holdings

Understand Procter & Gamble Hygiene & Health Care ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
Procter And Gamble Overseas India B.V.	68.73%
Sbi Focused Equity Fund	5.58%
Life Insurance Corporation Of India	4.08%
Temple Trees Impex And Investment Private Limited	1.91%
Icici Prudential Bluechip Fund	1.64%
General Insurance Corporation Of India	1.63%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Procter & Gamble Hygiene & Health Care Better than it's peers?

Detailed comparison of Procter & Gamble Hygiene & Health Care against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
HINDUNILVR	Hindustan Unilever	5.87 LCr	64.89 kCr	-6.10%	-15.80%	54.37	9.04	-	-
NESTLEIND	Nestle India	2.22 LCr	20.51 kCr	-0.30%	-16.00%	70.94	10.84	-	-
GODREJCP	Godrej Consumer Products	1.2 LCr	15.02 kCr	-5.20%	-15.20%	64.99	8.02	-	-
MARICO	Marico	90.85 kCr	11.67 kCr	-3.40%	-	54.38	7.78	-	-
DABUR	Dabur India	87.42 kCr	13.18 kCr	-5.40%	-22.10%	48.99	6.63	-	-

Sector Comparison: PGHH vs Personal Products

Comprehensive comparison against sector averages

Comparative Metrics

PGHH metrics compared to Personal

Category	PGHH	Personal
PE	59.26	53.12
PS	12.96	8.08
Growth	-19.7 %	0.3 %

Performance Comparison

PGHH vs Personal (2021 - 2025)

Key Insights

1. PGHH is among the Top 5 Personal Care companies by market cap.
2. The company holds a market share of 7.2% in Personal Care.
3. In last one year, the company has had a below average growth that other Personal Care companies.

Income Statement for Procter & Gamble Hygiene & Health Care

Standalone figures (in Rs. Crores)

AnnualQuarterly

Description	(%) Q/Q	Mar-2025	Jun-2024	Jun-2023	Jun-2022	Jun-2021	Jun-2020
Revenue From Operations	-19.8%	3,374	4,206	3,918	3,901	3,574	3,002
Other Income	-29.4%	37	52	41	24	39	44
Total Income	-19.9%	3,412	4,258	3,958	3,925	3,614	3,046
Cost of Materials	-26.6%	567	772	848	1,260	1,128	1,066
Purchases of stock-in-trade	-21.2%	673	854	824	305	41	52
Employee Expense	-28.6%	176	246	206	214	202	173
Finance costs	-50%	14	27	11	11	6.11	6.07
Depreciation and Amortization	-43.6%	32	56	58	53	48	48
Other expenses	-22.1%	1,072	1,376	1,180	1,297	1,329	1,114
Total Expenses	-23.2%	2,550	3,319	3,119	3,135	2,744	2,452
Profit Before exceptional items and Tax	-8.2%	862	939	839	790	870	594
Total profit before tax	-8.2%	862	939	839	790	870	594
Current tax	-16.1%	231	275	172	207	227	153
Deferred tax	49.3%	-5.18	-11.19	-11.14	7.71	-8.89	7.75
Total tax	-14.4%	226	264	161	214	218	161
Total profit (loss) for period	-5.6%	637	675	678	576	652	433
Other comp. income net of taxes	-278.3%	-7.06	5.52	-7.48	5.46	1.34	-1.69
Total Comprehensive Income	-7.5%	630	681	671	581	653	431
Earnings Per Share, Basic	-5.7%	196.11	207.95	208.91	177.37	200.79	133.42
Earnings Per Share, Diluted	-5.7%	196.11	207.95	208.91	177.37	200.79	133.42

Description	(%) Q/Q	Jun-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023
Revenue From Operations	-24.9%	937	1,248	1,135	932	1,002	1,133
Other Income	-23.2%	7.69	9.71	8.5	7.31	14	16
Total Income	-24.8%	945	1,257	1,144	939	1,016	1,149
Cost of Materials	-17.3%	164	198	194	177	164	215
Purchases of stock-in-trade	-18%	202	246	217	232	181	219
Employee Expense	-27.7%	48	66	61	67	60	55
Finance costs	-116.5%	0.07	6.62	1.91	-0.08	22	2.55
Depreciation and Amortization	-9%	9.09	9.89	12	13	15	14
Other expenses	-24.3%	281	371	363	366	347	318
Total Expenses	-23.9%	680	893	858	827	782	840
Profit Before exceptional items and Tax	-27.3%	265	364	285	112	234	309
Total profit before tax	-27.3%	265	364	285	112	234	309
Current tax	-23.7%	72	94	80	33	88	79
Deferred tax	-137%	0.8	1.54	-6.48	-1.67	-8.2	0.23
Total tax	-24.2%	73	96	73	31	80	80
Total profit (loss) for period	-28.7%	192	269	212	81	154	229
Other comp. income net of taxes	63.2%	-1.77	-6.52	1.39	-1.39	3.21	5.57
Total Comprehensive Income	-27.6%	190	262	213	80	158	234
Earnings Per Share, Basic	-28.8%	59.17	82.74	65.28	24.97	47.56	70.51
Earnings Per Share, Diluted	-28.8%	59.17	82.74	65.28	24.97	47.56	70.51

Balance Sheet for Procter & Gamble Hygiene & Health Care

Standalone figures (in Rs. Crores)

Description	(%) Q/Q	Mar-2025	Dec-2024	Jun-2024	Dec-2023	Jun-2023	Dec-2022
Cash and cash equivalents	-39.8%	466	774	574	688	964	932
Loans, current	6.1%	4.63	4.42	3.89	354	3.69	4.49
Total current financial assets	-29.9%	825	1,177	922	1,383	1,231	1,224
Inventories	-8.3%	221	241	226	185	220	206
Current tax assets	-	-	0	0	0	45	0
Total current assets	-25.7%	1,091	1,468	1,200	1,610	1,496	1,491
Property, plant and equipment	-9.7%	131	145	139	160	170	153
Capital work-in-progress	25%	41	33	28	20	23	43
Loans, non-current	11.8%	39	35	31	28	27	26
Total non-current financial assets	-4.5%	43	45	41	38	36	36
Total non-current assets	3%	648	629	659	616	642	513
Total assets	-16.3%	1,755	2,097	1,859	2,227	2,137	2,004
Total non-current financial liabilities	-1%	0.01	0.02	0.01	0.26	0.84	1.37
Provisions, non-current	6.4%	117	110	103	108	105	96
Total non-current liabilities	6.4%	117	110	103	109	106	98
Total current financial liabilities	-12.9%	831	954	886	959	1,000	948
Provisions, current	0%	13	13	11	5.13	10	8.44
Current tax liabilities	-	-	6.91	36	42	26	5.16
Total current liabilities	-13.5%	901	1,041	981	1,065	1,085	1,018
Total liabilities	-11.6%	1,018	1,151	1,084	1,174	1,191	1,115
Equity share capital	0%	32	32	32	32	32	32
Total equity	-22.1%	737	946	775	1,052	946	889
Total equity and liabilities	-16.3%	1,755	2,097	1,859	2,227	2,137	2,004

Cash Flow for Procter & Gamble Hygiene & Health Care

Standalone figures (in Rs. Crores)

Description	(%) Q/Q	Mar-2025	Jun-2024	Jun-2023	Jun-2022	Jun-2021	Jun-2020
Finance costs	105%	14	7.34	11	7.76	-	-
Change in inventories	64.8%	-5.81	-18.37	5.26	15	-	-
Depreciation	-43.6%	32	56	58	53	-	-
Impairment loss / reversal	-108.3%	0	13	0	0	-	-
Unrealised forex losses/gains	-	0	0	0.38	-0.83	-	-
Adjustments for interest income	-37.2%	28	44	35	23	-	-
Share-based payments	-31.7%	6.12	8.5	8.48	10	-	-
Net Cashflows from Operations	10.7%	829	749	1,055	822	-	-
Income taxes paid (refund)	-12.6%	243	278	230	249	-	-
Other inflows (outflows) of cash	-	6.85	0	0	0	-	-
Net Cashflows From Operating Activities	26%	593	471	826	573	-	-
Proceeds from sales of PPE	-243.9%	0.41	1.41	0.02	0.07	-	-
Purchase of property, plant and equipment	22.7%	55	45	44	50	-	-
Cash receipts from repayment of advances and loans made to other parties	-100.1%	0	700	0	0	-	-
Interest received	-46.5%	24	44	35	23	-	-
Other inflows (outflows) of cash	-	-4.01	0	0	0	-	-
Net Cashflows From Investing Activities	-58900%	-34.28	1.06	-9.91	-26.85	-	-
Payments of lease liabilities	-	0.78	0	0	-1.63	-	-
Dividends paid	-22.7%	665	860	471	568	-	-
Interest paid	-143.9%	0	0.59	5.26	2.51	-	-
Net Cashflows from Financing Activities	22.7%	-666.23	-861.75	-477.01	-568.94	-	-
Net change in cash and cash eq.	72.3%	-107.3	-390.16	339	-22.69	-	-

What does Procter & Gamble Hygiene & Health Care Ltd. do?

Personal Care•Fast Moving Consumer Goods•Mid Cap

Procter & Gamble Hygiene & Health Care is a prominent Personal Care company with the stock ticker PGHH. It boasts a substantial market capitalization of Rs. 46,360.4 Crores.

The company specializes in the manufacture and sale of branded packaged fast-moving consumer goods, focusing on feminine care and healthcare sectors both in India and internationally. Procter & Gamble Hygiene and Health Care operates through two main segments: Healthcare Products and Hygiene Products.

In terms of offerings, the company provides a wide range of health care products, which include ointments, creams, cough drops, and tablets. Its hygiene product line encompasses feminine hygiene products and other skin care items, including feminine care pads. Additionally, they offer baby care products such as nappies, pants, and baby wipes, as well as grooming products, laundry products, hair care products, home care products, and a variety of oral care products.

Procter & Gamble Hygiene & Health Care markets its products under well-known brands like Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice. Distribution occurs through various channels, including mass merchandisers, grocery stores, membership clubs, drugstores, department stores, and high-frequency stores.

Incorporated in 1964 and based in Mumbai, India, Procter & Gamble Hygiene and Health Care operates as a subsidiary of The Procter & Gamble Company. Over the past 12 months, it has generated a revenue of Rs. 4,355.8 Crores and has been profitable, with a profit of Rs. 715.9 crores recorded in the previous four quarters.

The company also rewards its investors with dividends, having a yield of 1.44% per year. In the last year, it returned Rs. 205 dividend per share. The company's revenue has experienced a growth rate of 16.8% over the past three years, demonstrating its robust performance in the marketplace.

Industry Group:Personal Products

Employees:439

Website:in.pg.com

PGHH - Procter & Gamble Hygiene & Health Care Ltd. Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

The Bad News

The Good News

Updates from Procter & Gamble Hygiene & Health Care

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Procter & Gamble Hygiene & Health Care Ltd. do?